Highbridge Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
TCM
O
CCA
Highbridge Capital Management's RGEN Position: Q4 2017 in Review
Highbridge Capital Management sold out of Repligen (RGEN) in Q4 2017, closing a stake of 13,845 shares — an estimated $531K sold.
Highbridge Capital Management first reported a position in RGEN in Q3 2016 and held it in 2 quarters. The position peaked at $531K in Q3 2017. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2017.
- Highbridge Capital Management reported no remaining Repligen position as of Q4 2017 after selling out during the quarter.
- Highbridge Capital Management sold 13,845 Repligen shares in Q4 2017, an estimated $531K.
- Highbridge Capital Management first reported a position in Repligen in Q3 2016 and held it in 2 quarters.
- Highbridge Capital Management's Repligen position peaked at $531K in Q3 2017.
- 184 funds tracked by Wall St. Rank held Repligen as of Q4 2017.
Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.